320
Participants
Start Date
January 10, 2023
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
No intervention
No intervention
Geneva University Hospital, Geneva
University of Geneva, Switzerland
OTHER
ModernaTX, Inc.
INDUSTRY
University Hospital, Geneva
OTHER